More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

Patients with late-onset rheumatoid arthritis face poorer physical outcomes and higher risks of death and malignancy, ...

Disease Activity (CDAI): • Both arms achieved significant early gains ... In conclusion, patients with late-onset rheumatoid arthritis demonstrated similar disease activity improvements as ...

A rheumatoid factor (RF) test is a blood test that can help diagnose rheumatoid arthritis (RA). The test measures the amount of rheumatoid factor in your blood. Rheumatoid factor is an autoantibody ...

This study utilizes the Complex Dietary Antioxidant Index (CDAI) to evaluate the combined effects of various dietary antioxidants in the diet. The goal is to investigate the relationship between CDAI ...